We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BMG LABTECH

BMG LABTECH is a manufacturer of a wide range of dedicated and multi-mode microplate instruments ranging from single-... read more Featured Products: More products

Download Mobile App




Circulating ACE2 Activity Predicts Mortality and Severity in COVID-19 Patients

By LabMedica International staff writers
Posted on 16 Dec 2021
Coronavirus disease 2019 (COVID-19) has been associated with significant morbidity and mortality worldwide in the last two years. More...
This disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Angiotensin-converting enzyme 2 (ACE2) represents the main receptor for SARS-CoV-2 to enter endothelial cells. ACE2 mediates the infection of endothelial cells, which induces endothelial activation and damage resulting in substantial release of von Willebrand factor and enhanced levels of soluble E-selectin.

Medical Laboratorians at the University of Debrecen (Debrecen, Hungary) recruited for a retrospective clinical study, 176 consecutive COVID-19 patients older than 18 years of age from two medical centers. These subjects suffered from different degrees of acute respiratory distress at admission and were confirmed to be positive for COVID-19 disease by reverse transcription polymerase chain reaction (RT-qPCR) test of a nasopharyngeal swab.

Two-thirds of these patients had a positive hemoculture (e.g. Escherichia coli, Klebsiella pneumoniae, Enterococcus faecalis, or Streptococcus pneumoniae), while the rest of individuals were culture-negative. All subjects had peripheral blood samples drawn at admission, and follow-up samples were also available before discharge or death in case of 106 subjects. The analysis of serum ACE2 activity was performed by a specific quenched fluorescent substrate (Peptide2, Chantilly, VA, USA). The cleavage of the quenched Mca-APK(Dnp) to liberate the fluorescent K(Dnp) was recorded using 340-nm excitation and 405-nm emission filters in a CLARIOstar microplate reader (BMG Labtech, Ortenberg, Germany).

Routinely available laboratory serum tests (i.e. CRP, PCT, IL-6, cTnT and ferritin) were determined by electro-chemiluminescent immunoassays on a Cobas e 411 analyzer, while enzyme activities (i.e. AST, ALT, LDH) and creatinine with urea levels were analyzed by kinetic colorimetric assays on a Cobas 8000 analyzer (Roche Diagnostics, Mannheim, Germany).

The investigators reported that initial ACE2 activity was significantly higher in critically ill COVID-19 patients (54.4 [36.7-90.8] mU/L) than in severe COVID-19 (34.5 [25.2-48.7] mU/L) and non-COVID-19 sepsis patients (40.9 [21.4-65.7] mU/L) regardless of comorbidities. Further, there was a tendency for higher ACE2 activity in relation to increasing age regardless of disease severity. Circulating ACE2 activity correlated with inflammatory biomarkers and was further elevated during hospital stay in critically ill patients. Based on ROC-curve analysis and logistic regression test, baseline ACE2 independently indicated the severity of COVID-19 with an AUC value of 0.701. Overall, non-survivors demonstrated significantly higher ACE2 activities (54.6 [IQR 37.3-94.7] mU/L) at hospital admission compared with survivors (35.6 [25.3-58.5] mU/L).

Miklós Fagyas, MD, PhD, an assistant professor and lead author of the study, said, “Serum ACE2 activity at hospital admission correlates with COVID-19 severity and predicts mortality, independently of the pulmonary function (Horowitz index). It appears that serum ACE2 is a non-specific biomarker in systemic inflammation, since it is also elevated in severe sepsis.” The study was published on November 25, 2021 in the International Journal of Infectious Diseases.

Related Links:
University of Debrecen
Peptide2
BMG Labtech
Roche Diagnostics



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study has linked blood proteins to Alzheimer’s disease and memory loss (Photo courtesy of Shutterstock)

Blood Test Could Detect Proteins Linked to Alzheimer's Disease and Memory Loss

Alzheimer’s disease has long been associated with sticky amyloid plaques in the brain, but these markers alone do not fully explain the memory loss and cognitive decline patients experience.... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.